Home » Topics » BioWorld Science

BioWorld Science
RSS

Pharmacia & Upjohn terminates Hemopure codevelopment agreement

July 12, 1996

Results of fat accumulation/PAI-1 levels relationship study disclosed

July 12, 1996

Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb

July 12, 1996

(+)-Sch-58053: Schering-Plough's cholesterol absorption inhibitor

July 12, 1996

Pfizer and Warner-Lambert sign atorvastatin agreement

July 12, 1996

Cathepsin B and L inhibitors in Fujisawa's pipeline

July 12, 1996

Non-steroidal compounds for postmenopausal disorders described by Lilly

July 12, 1996

IB-367: IntraBiotic's first drug candidate

July 12, 1996

Multidrug resistance modifiers from Vertex

July 12, 1996

Interim phase I/IIa results for Genta's G-3139 as non-Hodgkin's lymphoma agent

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...